Correction to: npj Vaccines https://doi.org/10.1038/s41541-024-00818-y, published online 21 February 2024
In the original version of this Meeting Report, the incorrect statement “Out of nine HIV-1 vaccine efficacy trials completed so far, all but one demonstrated correlates of protection4” was inserted by mistake. The correct statement should have been “Out of nine HIV-1 vaccine efficacy trials completed so far, only one demonstrated correlates of protection4”. The correct statement is now shown in both the PDF and HTML versions of this Meeting Report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Maciel, M., Amara, R.R., Bar, K.J. et al. Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report. npj Vaccines 9, 61 (2024). https://doi.org/10.1038/s41541-024-00852-w
Published:
DOI: https://doi.org/10.1038/s41541-024-00852-w
